Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010
Lipocine to Present at Biotech Showcase 2024
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
Alopecia Market Size Is Expected To Reach $7.8 Billion In 2028 At A CAGR Of 7.9% As Per The Business Research Company's Alopecia Global Market Report 2024
First Shipment of RiVive™ Brings Life-saving Over-The-Counter Nalxone Nasal Spray One Step Closer to Those Who Need It Most
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
 6   7   8   9   10     11    12   13   14   15   16 
 <<   <   >   >>